SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-222471
Filing Date
2020-08-17
Accepted
2020-08-17 16:30:52
Documents
1
Group Members
ABUDE UMARIPILLAR INVEST CORPPILLAR PARTNERS FOUNDATIONPILLAR PHARMACEUTICALS 6, L.P.PILLAR PHARMACEUTICALS II, L.P.PILLAR PHARMACEUTICALS III, L.P.PILLAR PHARMACEUTICALS IV, L.P.PILLAR PHARMACEUTICALS V, L.P.YOUSSEF EL ZEIN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d61505dsc13da.htm SC 13D/A 240021
  Complete submission text file 0001193125-20-222471.txt   242120
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Subject) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50211 | Film No.: 201110575
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PILLAR INVEST OFFSHORE SAL STARCO CENTER BLOC B FL3, OMAR DAOUK ST BEIRUT M8 2020-3313
Business Address C/O PILLAR INVEST OFFSHORE SAL STARCO CENTER BLOC B FL3, OMAR DAOUK ST BEIRUT M8 2020-3313 0119611363362
Pillar Pharmaceuticals I LP (Filed by) CIK: 0001534425 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A